2002
DOI: 10.1054/ijom.2001.0143
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Bioglass/dextran composite as a bone graft substitute

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
54
0
2

Year Published

2003
2003
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(58 citation statements)
references
References 9 publications
2
54
0
2
Order By: Relevance
“…This avoids second donor-site morbidity, reduces the surgical time, length of the hospital stay, chances of graft rejection, and wound infection as well as cut down on the cost factor for the patient. [14][15][16][17][18][19][20] In the present study, we did not encounter any complication except for pain for duration of 2 weeks in 3 patients and parasthesia for 3 months in 6 cases, which was partly attributed to the use of Carnoy's solution. The pain was successfully managed by routine analgesic therapy (500 mg Paracetamol three times a day for three day).…”
Section: Resultssupporting
confidence: 46%
See 1 more Smart Citation
“…This avoids second donor-site morbidity, reduces the surgical time, length of the hospital stay, chances of graft rejection, and wound infection as well as cut down on the cost factor for the patient. [14][15][16][17][18][19][20] In the present study, we did not encounter any complication except for pain for duration of 2 weeks in 3 patients and parasthesia for 3 months in 6 cases, which was partly attributed to the use of Carnoy's solution. The pain was successfully managed by routine analgesic therapy (500 mg Paracetamol three times a day for three day).…”
Section: Resultssupporting
confidence: 46%
“…[11][12][13][14][15] Spontaneous bone regeneration of large defects is an unexpected phenomenon, but in the presence of intact periosteum as a source of osteogenic tissue, mandibular stabilization, and young age of the patients, spontaneous bone regeneration of mandibular defects can occur. [16][17][18] The spontaneous bone regeneration in our case studies had a cyst size ranging from 3 to 10 cm, mean size being 4.8 cm. All were treated by enucleation and left for spontaneous bone healing.…”
Section: Resultsmentioning
confidence: 72%
“…4 Settable, weight-bearing bone grafts ideally exhibit both initial bone-like mechanical properties and also remodel with minimal resorption gaps such that the strength of the graft exceeds that of host bone during all stages of healing. Injectable bone void fillers (BVFs) include nonsetting allograft 5 and nonallogenic pastes, 6 which are typically delivered using viscous carriers (e.g., sodium hyaluronate, 7 glycerol, 8 or dextran 9 ) resulting in weak mechanical properties. Resorbable CPCs, [10][11][12][13] such as beta-tricalcium phosphate (b-TCP, slowly resorbed by osteoclasts) or calcium sulfate (CSH) and brushite (undergo dissolution), have also been used to enhance bone healing.…”
Section: Introductionmentioning
confidence: 99%
“…These were followed by more than a dozen other commercial CPC formulations (Table 2). Recently, efforts towards composites of hydrogels and bone substitutes (Chan et al, 2002;Chazono et al, 2004;Dupraz et al, 1998;Grimandi et al, 1998;Ito, 1991;Maruyama et al, 1995;Momota et al, 2002;Pompili et al, 1998) have been intensified and several products have been launched (Table 3). These efforts are expressed by a rapid increase of the number of publications.…”
Section: Introductionmentioning
confidence: 99%